Medxy AI – Page 15

Optimizing Carrier Screening: Insights and Recommendations From a Maternal-Fetal Medicine Practice

By MedXY 10/06/2026

Carrier screening timing and protocols vary widely, often delaying risk assessment and increasing patient distress. Early or prepregnancy screening with concurrent partner testing and thorough counseling improves reproductive decision-making and equity in detecting genetic risks.

Dermatology news OB/GYN & Women's Health

Comparing CO2 Laser Therapy and Topical Clobetasol in Vulvar Lichen Sclerosus: Breakthroughs in Symptom Management

By MedXY 10/06/2026

A randomized controlled trial demonstrates superior symptom relief with fractional CO2 laser treatment over topical clobetasol in women with vulvar lichen sclerosus, suggesting a novel therapeutic approach.

news OB/GYN & Women's Health

Patient-Specific Pessaries After Suboptimal Outcomes With Standard Pessary Use: A Multicenter Retrospective Case Series

By MedXY 10/06/2026

This retrospective case series evaluates patient-specific pessaries' success in individuals with prior suboptimal outcomes using standard pessaries for pelvic organ prolapse across Canadian clinical sites.

news Oncology Pathology & Lab Medicine

TESERA: Advancing Morphologic Subtyping and Prognostic Stratification in Hepatocellular Carcinoma Using H&E Whole-Slide Images

By MedXY 10/06/2026

TESERA leverages computational pathology to classify hepatocellular carcinoma into biologically distinct morphologic subtypes from standard H&E slides, offering accurate prognosis stratification competitive with clinical and molecular markers.

Diabetes & Endocrinology news Oncology

Exceptional and Durable Response to Selpercatinib in a Patient with Apparently RET-Negative, HRAS-, and NF1-Mutated Metastatic Medullary Thyroid Carcinoma

By MedXY 10/06/2026

A 50-year-old woman with metastatic medullary thyroid carcinoma (MTC) lacking RET alterations exhibited a remarkable sustained response to selpercatinib, suggesting potential efficacy beyond RET-mutated cases.

Gastroenterology Infectious Diseases news

High Efficacy and Tolerability of an 8-Week Bemnifosbuvir and Ruzasvir Regimen in Chronic Hepatitis C: Insights from a Phase 2 Study

By MedXY 10/05/2026

An 8-week course of bemnifosbuvir and ruzasvir showed high sustained virologic response rates with excellent safety in treatment-naïve chronic hepatitis C patients across genotypes, including those with baseline resistance mutations.

Gastroenterology news Oncology

Harnessing Circulating Tumour DNA for Minimal Residual Disease Detection in Colorectal Cancer: Insights from the INTERCEPT Programme

By MedXY 10/05/2026

The INTERCEPT study demonstrates that longitudinal ctDNA testing effectively detects minimal residual disease post-curative treatment in colorectal cancer, enhancing recurrence prediction and refining risk stratification to guide future interventions.

Gastroenterology news

An Unexpected Cause of Severe Steatohepatitis in a Young Male

By MedXY 10/05/2026

A 24-year-old obese male presents with incidental liver abnormalities; imaging reveals severe steatohepatitis with unusual features prompting detailed diagnostic evaluation and management strategies.

Emergency Medicine Neurology news

Operational, Ethical, and Technological Priorities for Prehospital Stroke Trials in Conventional EMS: An Expert Consensus Explained

By MedXY 10/05/2026

A clear, clinician-focused summary of the 2026 expert consensus on designing, conducting, and analyzing prehospital stroke trials in routine EMS systems—covering patient identification, consent, trial design, endpoints, and technology priorities.

Clinical Updates Neurology news

Beyond the Threshold: Continuous Creatinine Change and Outcomes After Endovascular Thrombectomy for Acute Ischemic Stroke

By MedXY 10/05/2026

Early continuous creatinine changes within 48 hours after EVT correlate with graded risks of poor 90-day functional outcome and in-hospital mortality, revealing prognostic nuances beyond traditional dichotomous CA-AKI definitions.

Cardiology Neurology news

Evaluating Left Atrial Appendage Closure Versus Oral Anticoagulation for Stroke Prevention in Atrial Fibrillation: An Updated Meta-Analysis

By MedXY 10/05/2026

This meta-analysis consolidates data from six RCTs comparing left atrial appendage closure (LAAC) to oral anticoagulation for stroke prevention in atrial fibrillation, highlighting reduced bleeding with LAAC but increased ischemic stroke risk.

Critical Care Neurology news

Evolving Patterns in Withdrawal of Life-Sustaining Treatment Among Traumatic Brain Injury Patients: Insights From a Decade of ACS Trauma Data

By MedXY 10/05/2026

A decade-long analysis reveals a modest decline and delayed timing in withdrawal of life-sustaining treatment among patients with traumatic brain injury, highlighting evolving prognostic attitudes and clinical decision-making.

Neurology news

Skin Denervation as a Biomarker Linked to Cognitive Decline and Brain Atrophy in Parkinson Disease

By MedXY 10/05/2026

Peripheral skin nerve fiber loss correlates with cognitive impairment and brain atrophy in Parkinson disease, suggesting a peripheral-central neurodegenerative axis with potential diagnostic value.

Hematology-Oncology Neurology news

Midterm Cognitive Outcomes After CAR T-Cell Therapy in CNS Lymphoma Patients: Encouraging Evidence Beyond Acute Neurotoxicity

By MedXY 10/05/2026

This study assesses medium-term cognitive changes in CNS lymphoma patients treated with CAR T-cell therapy, revealing cognitive stability or improvement up to 12 months post-treatment, despite initial neurotoxicity risks.

Neurology news

Evaluating SAR443820, a RIPK1 Inhibitor, in Amyotrophic Lateral Sclerosis: Insights from the Phase 2 HIMALAYA Trial

By MedXY 10/05/2026

This phase 2 trial assessed SAR443820, a RIPK1 inhibitor, in ALS patients; it showed no clinical efficacy and increased hepatic side effects, indicating limited therapeutic potential in ALS.

Diabetes & Endocrinology Nephrology news

Liver-Derived Apolipoprotein J Drives Diabetic Kidney Injury by Disrupting TFEB-Mediated Lipid Regulation

By MedXY 10/05/2026

This study reveals that liver-secreted apolipoprotein J accumulates in renal tubules, disrupting TFEB-mediated lipid homeostasis and exacerbating diabetic kidney disease, highlighting a novel therapeutic target with the ApoJ antagonist MK53.

Diabetes & Endocrinology Gastroenterology news

Head-to-Head Comparison of Empagliflozin and Dapagliflozin on Liver Outcomes in Type 2 Diabetes with MASLD

By MedXY 10/05/2026

A large Korean cohort study found similar hepatic benefits between empagliflozin and dapagliflozin in patients with type 2 diabetes and metabolic dysfunction-associated steatotic liver disease, with no difference in risk of severe liver complications.

Diabetes & Endocrinology news

Enhanced Glycaemic Control in Type 2 Diabetes: Digital Therapeutics Combined with CGM Show Superior Outcomes

By MedXY 10/05/2026

A 6-month RCT in non-insulin-treated type 2 diabetes demonstrates that combining the digital therapeutic glucura with CGM significantly improves HbA1c, weight, and patient well-being beyond CGM and standard care alone.

Diabetes & Endocrinology news OB/GYN & Women's Health

Nadir Prolactin-Guided Cabergoline Therapy: Advancing Durable Remission and Safe Pregnancy in Prolactinoma Management

By MedXY 10/05/2026

Individualized cabergoline dosing guided by nadir prolactin levels achieves durable remission and safe pregnancy outcomes in women with prolactinomas, including those resistant or intolerant to bromocriptine.

Diabetes & Endocrinology news

Baseline Plasma Metabolites Predict Long-Term Glycemic Outcomes in Prediabetes: Insights from the PROP-ABC Study

By MedXY 10/05/2026

This study identifies baseline plasma metabolites, specifically 2hr plasma glucose and ceramide C18:0/C18:1 ratio, as predictors of persistent prediabetes vs. normoglycemia following lifestyle intervention over 5 years.

Optimizing Carrier Screening: Insights and Recommendations From a Maternal-Fetal Medicine Practice

Comparing CO2 Laser Therapy and Topical Clobetasol in Vulvar Lichen Sclerosus: Breakthroughs in Symptom Management

Patient-Specific Pessaries After Suboptimal Outcomes With Standard Pessary Use: A Multicenter Retrospective Case Series

TESERA: Advancing Morphologic Subtyping and Prognostic Stratification in Hepatocellular Carcinoma Using H&E Whole-Slide Images

Exceptional and Durable Response to Selpercatinib in a Patient with Apparently RET-Negative, HRAS-, and NF1-Mutated Metastatic Medullary Thyroid Carcinoma

High Efficacy and Tolerability of an 8-Week Bemnifosbuvir and Ruzasvir Regimen in Chronic Hepatitis C: Insights from a Phase 2 Study

Harnessing Circulating Tumour DNA for Minimal Residual Disease Detection in Colorectal Cancer: Insights from the INTERCEPT Programme

An Unexpected Cause of Severe Steatohepatitis in a Young Male

Operational, Ethical, and Technological Priorities for Prehospital Stroke Trials in Conventional EMS: An Expert Consensus Explained

Beyond the Threshold: Continuous Creatinine Change and Outcomes After Endovascular Thrombectomy for Acute Ischemic Stroke

Evaluating Left Atrial Appendage Closure Versus Oral Anticoagulation for Stroke Prevention in Atrial Fibrillation: An Updated Meta-Analysis

Evolving Patterns in Withdrawal of Life-Sustaining Treatment Among Traumatic Brain Injury Patients: Insights From a Decade of ACS Trauma Data

Skin Denervation as a Biomarker Linked to Cognitive Decline and Brain Atrophy in Parkinson Disease

Midterm Cognitive Outcomes After CAR T-Cell Therapy in CNS Lymphoma Patients: Encouraging Evidence Beyond Acute Neurotoxicity

Evaluating SAR443820, a RIPK1 Inhibitor, in Amyotrophic Lateral Sclerosis: Insights from the Phase 2 HIMALAYA Trial

Liver-Derived Apolipoprotein J Drives Diabetic Kidney Injury by Disrupting TFEB-Mediated Lipid Regulation

Head-to-Head Comparison of Empagliflozin and Dapagliflozin on Liver Outcomes in Type 2 Diabetes with MASLD

Enhanced Glycaemic Control in Type 2 Diabetes: Digital Therapeutics Combined with CGM Show Superior Outcomes

Nadir Prolactin-Guided Cabergoline Therapy: Advancing Durable Remission and Safe Pregnancy in Prolactinoma Management

Baseline Plasma Metabolites Predict Long-Term Glycemic Outcomes in Prediabetes: Insights from the PROP-ABC Study

Expanding the Genetic Landscape in Ovarian Carcinoma: Insights from the PERSONA-Ovary Trial on Germline and Somatic Testing

Assessing Muscle Recovery: Responsiveness of the K-Force Grip Dynamometer in ICU-Acquired Weakness Patients

Long-Acting Injectable Cabotegravir-Rilpivirine Every 8 Weeks for Adolescents with HIV in Sub-Saharan Africa: Evidence from the LATA Trial and Contemporary Context

Optimizing Antibiotic Therapy for Community-Acquired Pneumonia in Children with Medical Complexity: Evidence for Narrow-Spectrum Use